Emerging Therapies Webcast a Great Success

     Translating today’s discoveries into tomorrow’s treatments and cures.  For years, PAN has led the effort to speed the translation of basic discoveries into the drugs that people living with chronic diseases need.

On June 24, PAN hosted the Emerging Therapies:  From Microscope to Marketplace Interactive Webcast at Georgetown University.  The Emerging Therapies Webcast, a live online broadcast, was an educational event for the Parkinson’s community and all disease and research communities.  This insightful discussion provided participants with a better understanding of how research is moved through the therapy development pipeline and, ultimately, into the hands of patients in the form of new therapies and drugs.  The discussion featured questions from the Webcast audience as well as the live audience at Georgetown University.  The panel consisted of:

Howard Federoff, M.D., Ph.D.
Executive Vice President for Health Sciences and
Executive Dean of the School of Medicine, Georgetown University -- Moderator

James P. Bennett, Jr., M.D., Ph.D.
Chair, Department of Neurology and Founding Director of the
Virginia Commonwealth University Parkinson's Disease and
Movement Disorders Multidisciplinary Research and Clinical Center

Story C. Landis, Ph.D.

Director, National Institute of Neurological Disorders and Stroke,
National Institutes of Health

Raymond T. Bartus, Ph.D.
Executive Vice President and Chief Scientific Officer, Ceregene, Inc.

Jackie Hunt Christensen
PAN Minnesota State Coordinator and Clinical Trial Participant

Janet Woodcock, M.D.
Director, Center for Drug Evaluation and Research,
Food and Drug Administration

The Webcast archive is available now and throughout the year for viewing at your convenience.  We encourage you to watch the presentation and learn about this vital issue.  The therapy development pipeline is hugely important to those hoping for new treatments and cures.  The discussion was not specific to Parkinson’s disease and is applicable to clinical research generally.  Simply visit PAN’s Web site and log in to view the Webcast.

The lively panel discussion generated far more questions than the panelists were able to respond to.  As a way to address these questions, PAN has created a discussion page posting a selection of questions from the Webcast.  We are encouraging researchers and clinicians to take this opportunity to respond to these questions and for others to post new questions arising from this Webcast.

Click here to watch
the Emerging Therapies Interactive Webcast.  To learn more about PAN and our programs, please visit our Web site.